Afya Limited Stock Price, News & Analysis

Afya Limited (Nasdaq: AFYA) reported significant growth for Q2 2022, with Adjusted Net Revenue up 51% YoY to R$576.1 million. Excluding acquisitions, revenue grew 19% to R$454 million. Adjusted EBITDA rose 37.1% to R$220.2 million, despite a decrease in EBITDA margin. Net Income surged 383.4% to R$106.1 million, with EPS increasing 522.2% to R$1.12. The company reaffirmed its 2022 guidance, expecting revenue between R$2.28 billion and R$2.36 billion. Solid cash conversion at 91% and a cash position of R$616.3 million were noted, alongside a 26.2% increase in digital services' active payers.

Afya Limited (NASDAQ: AFYA) will announce its Second-Quarter and First Half 2022 Financial Results on August 22, 2022, after market close. The conference call is scheduled for 5:00 PM ET and will be accessible via webcast. The company also disclosed sell-side analysts’ consensus figures, with estimated Net Revenue ranging from R$ 554 million to R$ 573 million and Adjusted EBITDA expected between R$ 211 million and R$ 224 million. The estimates were based on forecasts collected from analysts between July 15 and July 21, 2022.

Afya Limited (AFYA) has acquired Glic, a diabetes care app, through its subsidiary Afya Participações S.A. The purchase, valued at R$22 million in cash, aims to enhance Afya's digital services strategy. Glic boasts over 90,000 active users and 1,100 physicians, projecting gross revenues of R$3.7 million for 2022. An additional earn-out of up to R$12 million is contingent upon achieving specific revenue targets in 2023 and 2024. This acquisition strengthens Afya's position in the physician-patient relationship sector.

Afya Limited (Nasdaq: AFYA), a leader in medical education and digital health services in Brazil, reported a strong Q1 2022, with adjusted net revenue rising 41.0% to R$567.7 million, and adjusted EBITDA growing 30.4% to R$270.8 million, despite a decreased EBITDA margin of 47.7%. Net income reached R$134.9 million, a 19.1% increase YoY. Afya reaffirmed its full-year guidance for 2022, targeting adjusted net revenue between R$2.28 billion and R$2.36 billion, alongside strategic acquisitions to bolster its digital ecosystem. The company also demonstrated commitment to ESG initiatives.

Afya Limited (NASDAQ: AFYA) announced the closing of a transaction where Bertelsmann acquired 6,000,000 Class B shares at US$26.90 each, granting Bertelsmann a ~57.5% voting interest. The company has also extended CEO Virgilio Gibbon's contract through May 2027 to support its expansion in medical education and digital health strategies. Additionally, Benedikt Dalkmann was appointed to the board to enhance leadership diversity.

Afya Limited (AFYA) held its Annual General Meeting on April 12, 2022, where key resolutions were approved. This included the ratification of financial statements for the fiscal year ending December 31, 2021, and the approval of the Amended and Restated Memorandum and Articles of Association. These changes are subject to closing a transaction disclosed on March 4, 2022, between the Esteves Family and Bertelsmann SE & Co. KGaA. Further details are available on their website.

Afya Limited (NASDAQ: AFYA) announced that Bertelsmann SE & Co. KGaA will purchase 6,000,000 Class B shares at US$26.90 each. This transaction follows a prior disclosure on March 7, 2022. After the deal, Bertelsmann will hold a 57.5% voting interest, while the Esteves Family will control 33.1%. The anticipated closing date for the transaction is May 4, 2022, pending standard closing conditions. This move strengthens Bertelsmann's and the Esteves Family's influence over Afya's decision-making processes.

Afya Limited (NASDAQ: AFYA) announced the resignation of Mr. Paulo Passoni from its Board of Directors, effective immediately. He has been a board member since May 2021. Mrs. Maria Tereza Azevedo has been appointed as his successor, bringing extensive experience in investment and corporate finance from her roles at Softbank, Santander, and UBS. This change aims to enhance the board's diversity and strategic decision-making capabilities, with Azevedo's expertise in the education sector being particularly valuable for Afya's growth.